The testing of starting materials can be a nightmare for pharma companies!

To ensure patient safety, remove the risk of #manufacturing problems, and to comply with the appropriate authorities, its paramount to include the testing of starting materials in your overall production plan.

This age-old yet essential part of #drugdevelopment requires the combination of modern advanced techniques alongside established methods to ensure accurate reporting of identity, purity and quality.

Taking into account that suppliers of raw materials don’t supply only the pharmaceutical industry (which poses its own risks), and given that standard pharmacopeial tests are not always robust enough, it is key to choose a partner who is highly experienced and can assure the materials are tested correctly across all standards.

With over 20-years experience, QUINTA-ANALYTICA are able to offer a full suite of starting material testing services, including osmolality, optical rotation, identity tests, amino acid analyses, thermostability and many more.

With the awareness that suppliers often use non-compendial methods, avoiding unnecessary risk and getting your starting materials tested professionally is more important now than ever.

Contact us today to discuss your testing requirements.

Additional News

  • 3 September 2026

    Quinta-Analytica Expands HPLC Fleet to Strengthen Flexibility and Capacity for Clients

    New Thermo Scientific Vanquish Core joins an HPLC fleet of around 50 systems

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.